Large Pancreatic Cancer in the Elderly

Zhang Qunhua,Ni Quanxing,Zhang Yianling,Cao Guohai,Fu Deliang,Yao Qiyuan,Jin Chen,Yu Xianjun,Zhang Niu

DOI: https://doi.org/10.1007/bf02855649

2003-01-01

The Chinese-German Journal of Clinical Oncology

Abstract:Objective To elucidate contributing factors that lead to successful management of large pancreatic cancer in geriatric patients.Methods The study involved 74 patients with larger pancreatic malignancy. Risks and benefits of pancreaticoduodenectomy at an advanced age were analyzed retrospectively in 35 patients older than 70 years of age. Of them, 15 elderly patients were radically resected by "3 steps procedure". Conventional and regional pancreaticoduodenectomy was performed in 30 and 5 patients, respectively. The results achieved in these patients were compared with those observed in 39 younger patients. Results The 30-day mortality and morbidity rates for the elderly patients with large pancreatic cancer were 5.9% and 26.4% respectively; while for the younger patients, they were 5.2% and 18.4% respectively. A statistically significant correlation was observed between the presence of risk factors, the occurrence of complications, and the mortality rate. No difference was found between the two age groups when the risk factors were absent. The 5-year survival rate in the elderly patients and the younger patients was 11.7% and 15.7% respectively, with the difference being not significant. Conclusion Curative pancreaticoduodenectomy can be carried out safely in older patients, with long-term results comparable to those achieved in the younger patients. The preoperative interventional chemotherapy can provide an inflammatory edema wall between the tumor and portal vein, so as to decrease the portal vein resection rates.